New Delhi, Apr 17 (KNN) The Directorate General of Foreign Trade (DGFT) today said that the restrictions on exports of medicines made from Paracetamol amid the outbreak of Covid-19 have been removed.

However, restrictions on exports of Paracetamol active pharmaceutical ingredients (APIs or raw materials) will continue, DGFT said in a notification.

To export a product, which is under restricted category, an exporter requires no-objection certificate or permission of a licence from the DGFT.

"...The formulations made from Paracetamol (including fixed-dose combinations)...are made free for export with immediate effect. However, Paracetamol APIs will remain restricted for export," it said.

With the increasing cases of COVID-19 in the country, government on March 3 had put export restrictions on 26 pharma ingredients and medicines, including paracetamol.

On April 6 DGFT had removed the export restrictions on 24 APIs and formulations excluding Paracetamol. (KNN Bureau)